Opportunity Information: Apply for PA 10 270
Apply for PA 10 270
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Neuroscience Research on Drug Abuse (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Aug 20, 2010 and posted on Aug 20, 2010.
- Applicants must submit their applications by Sep 7, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $50,000.00 in funding.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments Native American tribal governments (Federally recognized) City or township governments Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) County governments For profit organizations other than small businesses Small businesses State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Neuroscience Research on Drug Abuse (R03) funding opportunity (PA-10-270) is a National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) grant program designed to support small, focused research projects that advance understanding of the brain-based processes and mechanisms involved in drug abuse and addiction. The emphasis is on neuroscience research that can clarify how substances affect neural systems and behavior, as well as studies that improve the tools and approaches used to investigate addiction-related neuroscience questions. The program is set up to encourage projects that are tightly scoped, achievable quickly, and capable of producing useful results without requiring the scale or long timeline of larger NIH awards.
This opportunity uses the NIH Small Research Grant (R03) mechanism, which is commonly used for early-stage or limited-scope work. It specifically supports activities such as pilot and feasibility studies, secondary analyses of existing datasets, small self-contained research projects, and the development of research methods or new technologies relevant to drug abuse and addiction neuroscience. A practical advantage of the R03 format is that preliminary data are not required, which makes it more accessible for applicants who are testing a new idea, exploring a new approach, or repurposing existing data to answer a well-defined question.
In terms of funding limits and duration, applicants may request up to $50,000 per year in direct costs for a period of up to two years. That creates a maximum of $100,000 in direct costs over the full project period. Because the R03 is intentionally a small grant mechanism, NIDA expects proposed aims to match that constraint, meaning the project should be feasible with limited resources and should not depend on extensive infrastructure, large-scale recruitment, or prolonged multi-phase experimentation. The number of awards is not fixed; it depends on the quality of submissions and how well proposals align with NIDA program priorities at the time of review.
This FOA is part of a set of parallel announcements with the same scientific scope but different NIH funding mechanisms. Applicants pursuing a slightly larger, exploratory project could look to the R21 companion opportunity (PA-10-269), while those proposing a more substantial, longer-term research program could consider the R01 companion opportunity (PA-10-268). This structure gives investigators multiple pathways to seek NIDA support depending on the maturity, size, and resource needs of the proposed work.
Eligibility is broad and includes many types of organizations, reflecting NIH’s aim to attract strong ideas from a wide range of institutional settings. Eligible applicants include public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (including small businesses, though the FOA is not limited to them), and multiple levels of government (state, county, city/township, special district governments, and public housing authorities). The eligibility language also explicitly includes a variety of mission-focused and historically underrepresented institution types and communities, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities, faith-based or community-based organizations, U.S. territories or possessions, and even non-U.S. entities (foreign organizations). No cost sharing or matching is required, which reduces barriers for smaller institutions or early-stage projects.
Administratively, the opportunity was posted on August 20, 2010, with the original and current closing date listed as September 7, 2013, and an archive date of October 8, 2013. The CFDA number associated with this program is 93.279 (Drug Abuse and Addiction Research Programs). The official announcement link is provided through the NIH Grants Guide, and NIH’s Office of Extramural Research (OER) web support contacts are listed for access or technical issues.
Overall, PA-10-270 is best viewed as a short-duration, limited-budget NIH research grant meant to help investigators generate initial findings, validate a method, analyze existing data in a new way, or build/benchmark tools and technologies that can push forward neuroscience research on drug abuse and addiction. It is especially well-suited for targeted questions where a modest amount of funding and a two-year window are sufficient to produce a clear, publishable result or a strong foundation for a future, larger NIH application.
Frequently Asked Questions (FAQs) - Neuroscience Research on Drug Abuse (R03) (PA-10-270)
What is the Neuroscience Research on Drug Abuse (R03) funding opportunity (PA-10-270)?
PA-10-270 is a National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) funding opportunity that uses the NIH Small Research Grant (R03) mechanism to support small, focused neuroscience research projects related to drug abuse and addiction.
What is the main purpose of this R03 program?
The program is designed to advance understanding of brain-based processes and mechanisms involved in drug abuse and addiction. It supports studies that clarify how substances affect neural systems and behavior, and it also supports work that improves the tools and approaches used to investigate addiction-related neuroscience questions.
What type of research does this FOA emphasize?
The emphasis is on neuroscience research that can explain substance effects on neural systems and behavior, and on research that strengthens neuroscience methods, tools, and technologies relevant to drug abuse and addiction.
What kinds of projects are a good fit for an R03 under PA-10-270?
This opportunity is intended for tightly scoped projects that are achievable quickly and can produce useful results without the scale or long timeline of larger NIH awards. It is particularly suitable for well-defined questions that can be answered within a limited budget and within a two-year project period.
What activities does the R03 mechanism support under this announcement?
The FOA specifically supports pilot and feasibility studies, secondary analyses of existing datasets, small self-contained research projects, and the development of research methods or new technologies relevant to neuroscience research on drug abuse and addiction.
Are pilot and feasibility studies allowed?
Yes. Pilot and feasibility studies are explicitly listed as supported activities under this R03 opportunity.
Can I apply to analyze existing data instead of collecting new data?
Yes. The FOA explicitly includes secondary analyses of existing datasets as an allowable and supported activity.
Does this FOA support method development or technology development?
Yes. The announcement supports the development of research methods or new technologies that are relevant to drug abuse and addiction neuroscience.
Is preliminary data required for an R03 application under this program?
No. A practical advantage of the R03 mechanism, as described in the opportunity, is that preliminary data are not required, which can help applicants who are testing a new idea or exploring a new approach.
How much funding can be requested?
Applicants may request up to $50,000 per year in direct costs.
What is the maximum project duration?
The project period may be up to two years.
What is the maximum total direct cost amount over the full project period?
Because the limit is up to $50,000 per year for up to two years, the maximum is $100,000 in direct costs over the entire project period.
How should applicants scope their research aims for this program?
NIDA expects proposed aims to match the intentionally small scale of the R03 mechanism. The project should be feasible with limited resources and should not depend on extensive infrastructure, large-scale recruitment, or prolonged multi-phase experimentation.
Is the number of awards fixed?
No. The number of awards is not fixed and depends on the quality of submissions and how well proposals align with NIDA program priorities at the time of review.
Are there related or companion funding opportunities with the same scientific scope?
Yes. This FOA is part of a set of parallel announcements with the same scientific scope but different NIH funding mechanisms.
What are the companion FOAs and how do they differ from the R03?
The companion opportunities mentioned are the R21 (PA-10-269) for a slightly larger exploratory project and the R01 (PA-10-268) for a more substantial, longer-term research program.
Who is eligible to apply?
Eligibility is broad. Eligible applicants include public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (including small businesses), and multiple levels of government (including state, county, city/township, special district governments, and public housing authorities).
Are small businesses eligible to apply?
Yes. For-profit organizations are eligible, including small businesses (though the FOA is not limited to small businesses).
Are nonprofit organizations required to have 501(c)(3) status to be eligible?
No. The eligibility language includes nonprofits with or without 501(c)(3) status.
Are government entities eligible applicants?
Yes. Multiple levels of government are listed as eligible, including state, county, city/township, special district governments, and public housing authorities.
Does the FOA include eligibility for mission-focused or historically underrepresented institution types?
Yes. The eligibility language explicitly includes HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities, and faith-based or community-based organizations.
Are U.S. territories or possessions included in eligibility?
Yes. U.S. territories or possessions are explicitly included.
Are foreign (non-U.S.) organizations eligible to apply?
Yes. The eligibility language explicitly includes non-U.S. entities (foreign organizations).
Is cost sharing or matching required?
No. The opportunity states that no cost sharing or matching is required.
When was this funding opportunity posted?
The opportunity was posted on August 20, 2010.
What was the closing date for this FOA?
The original and current closing date listed is September 7, 2013.
When was this FOA archived?
The archive date listed is October 8, 2013.
What is the CFDA number for this program?
The CFDA number provided is 93.279 (Drug Abuse and Addiction Research Programs).
Where is the official announcement posted?
The official announcement is available through the NIH Grants Guide (as referenced in the opportunity description).
Who should be contacted for access or technical issues related to NIH systems?
NIH Office of Extramural Research (OER) web support contacts are listed for access or technical issues.
What is this program best suited to help investigators accomplish?
It is best suited to generate initial findings, validate a method, analyze existing data in a new way, or build/benchmark tools and technologies that can advance neuroscience research on drug abuse and addiction, often producing a publishable result or a foundation for a future, larger NIH application.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Advancing Digitization of Biological Collections
Previous opportunity: Neuroscience Research on Drug Abuse (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 10 270
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 10 270) also looked into and applied for these:
| Funding Opportunity |
|---|
| Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) NIDA (R21/R33) Apply for PAS 10 274 Funding Number: PAS 10 274 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Pharmacological Development of Treatment Agents and Formulations for Tobacco Dependence (STTR R41 Apply for RFA DA 11 004 Funding Number: RFA DA 11 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Developing and Improving Institutional Animal Resources (G20) Apply for RFA RR 10 011 Funding Number: RFA RR 10 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Innovative Emerging Molecular Analysis Technologies (SBIR R43/R44) Apply for RFA CA 10 013 Funding Number: RFA CA 10 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Assay Development for High Throughput Screening for Nicotinic Receptor Subunits (R21) Apply for RFA DA 11 007 Funding Number: RFA DA 11 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) Apply for PAR 10 283 Funding Number: PAR 10 283 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Diagnostic and Therapeutic Agents Enabled by Nanotechnology (SBIR U43/U44) Apply for PAR 10 286 Funding Number: PAR 10 286 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| 2011 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) Apply for RFA DA 11 002 Funding Number: RFA DA 11 002 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pre Application for the 2011 NIDA Avant Garde Award Program for HIV/AIDS Research (X02) Apply for PAR 10 287 Funding Number: PAR 10 287 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Resource Related Research Projects for Development of Animal Models and Related Materials (R24) Apply for PAR 10 289 Funding Number: PAR 10 289 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research on Malignancies in the Context of HIV/AIDS (R01) Apply for PA 10 290 Funding Number: PA 10 290 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research on Malignancies in the Context of HIV/AIDS (R21) Apply for PA 10 291 Funding Number: PA 10 291 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Tumor Microenvironment Network (TMEN) (U54) Apply for RFA CA 10 021 Funding Number: RFA CA 10 021 Agency: National Institutes of Health Category: Education Health Funding Amount: $700,000 |
| Animal and Biological Material Resource Centers (P40) Apply for PAR 11 001 Funding Number: PAR 11 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Center Support Grants (CCSGs) for NCI designated Cancer Centers (P30) Apply for PAR 11 005 Funding Number: PAR 11 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Comprehensive Partnerships to Reduce Cancer Health Disparities (U54) Apply for RFA CA 11 001 Funding Number: RFA CA 11 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23) Apply for PA 11 009 Funding Number: PA 11 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R03) Apply for PA 11 008 Funding Number: PA 11 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R01) Apply for PA 11 006 Funding Number: PA 11 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R21) Apply for PA 11 007 Funding Number: PA 11 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 10 270", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.